NCT00000441

Drug Therapy for Alcohol Detoxification

Carbamazepine and Lorazepam in Outpatient Detoxification

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: —
• Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NIH
• Sex: All
• Age: 21 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This project will provide relevant clinical information for primary care practitioners treating alcohol withdrawal syndrome in outpatient settings. This double-blind, placebo- controlled clinical trial will compare the effectiveness of lorazepam (Ativan) and carbamazepine (Tegretol) in alcoholics who meet the criteria for a diagnosis of uncomplicated alcohol withdrawal syndrome. Participants are randomized to five days of treatment with a 1-week posttreatment followup.

Conditions

• Alcoholism

Interventions

Type	Name	Description
DRUG	lorazepam (Ativan)
DRUG	carbamazepine (Tegretol)

Timeline

• Completion: 2000-12-01
• First posted: 1999-11-03
• Last updated: 2005-06-24

Locations

1 site across 1 country: United States